Basic Information
| LncRNA/CircRNA Name | circMYLK |
| Synonyms | |
| Region | |
| Ensemble | |
| Refseq |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | laryngeal squamous cell carcinoma |
| ICD-0-3 | NA |
| Methods | qPCR |
| Sample | laryngeal squamous cell carcinoma tissues and cell lines |
| Expression Pattern | up-regulated |
| Function Description | We found that circMYLK was highly expressed in LSCC tissues and cell lines. circMYLK overexpression promoted LSCC cell proliferation and G1/S cell cycle transition; whereas circMYLK knockdown had the contrary effects. |
| Pubmed ID | 31427478 |
| Year | 2019 |
| Title | Circular RNA MYLK Serves as an Oncogene to Promote Cancer Progression via microRNA-195/cyclin D1 Axis in Laryngeal Squamous Cell Carcinoma |
External Links
| Links for circMYLK | GenBank HGNC NONCODE |
| Links for laryngeal squamous cell carcinoma | OMIM COSMIC |